Attention Deficit Disorder with Hyperactivity: all 1,547 studies

Page 16 of 16. Open to participants first (254), then studies with results posted, then the rest; newest registration first within each.

• A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT00190931Phase 4
• Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety DisorderCompletedNCT00190879Phase 4
• Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS)CompletedNCT00181857
• A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00181675Phase 4
• A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity DisorderCompletedNCT00181571Phase 4
• Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care SettingsCompletedNCT00179894Not applicable
• Treatment of Adult ADHD With Atomoxetine or Atomoxetine and BusparCompletedNCT00174226Phase 2
• Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity DisorderCompletedNCT00161161
• Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHDStatus unknownNCT00152750Phase 4
• Safety of SPD465 in Treating Adults With ADHD.CompletedNCT00152035Phase 3
• Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.CompletedNCT00152022Phase 3
• Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate TherapyCompletedNCT00151983Phase 3
• Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHDCompletedNCT00151970Phase 2
• Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS TrialsCompletedNCT00151957Phase 3
• Efficacy and Safety of SPD465 in Adults With ADHDCompletedNCT00150579Phase 3
• A Clinic-based Prevention Program for Families of Depressed MothersCompletedNCT00149812Phase 1
• Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain FunctioningStatus unknownNCT00143832
• Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity DisorderStatus unknownNCT00143767
• Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity DisorderCompletedNCT00142961Phase 2
• Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141063Phase 3
• Safety and Efficacy Study of Dexmethylphenidate in Children With ADHDCompletedNCT00141050Phase 3
• Methylphenidate Treatment for Cocaine Abuse and ADHD - 1CompletedNCT00136734Phase 1
• Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00116259Not applicable
• Brain Changes in Children and Adolescents With Behavioral ProblemsCompletedNCT00104039
• Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00100295Phase 2
• Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type ICompletedNCT00071656Not applicable
• Preventing Behavior Problems in Children With ADHDStatus unknownNCT00057668Phase 2
• Mental Health Services for Foster and Adopted ChildrenCompletedNCT00056303Phase 1
• Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity DisorderCompletedNCT00050050Phase 1
• Attention-Deficit Hyperactivity Disorder (ADHD) Study With AdultsCompletedNCT00048360Phase 3
• Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)CompletedNCT00046059
• Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in ChildrenCompletedNCT00031395Phase 3
• Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHDCompletedNCT00029614Phase 2
• Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy VolunteersCompletedNCT00026546
• Methylphenidate in Children and Adolescents With Pervasive Developmental DisordersCompletedNCT00025779Not applicable
• Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)CompletedNCT00018863Phase 3
• Attention Deficit Disorder and Exposure to LeadCompletedNCT00014898
• Treatment of Youth With ADHD and AnxietyCompletedNCT00012584Not applicable
• Nutrient Intake in Children With Attention Deficit Hyperactivity DisorderStatus unknownNCT00011466
• Brain Imaging in Children With AD/HDCompletedNCT00008892
• Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic StimulationCompletedNCT00001915
• Genetic Aspects of Neurologic and Psychiatric DisordersCompletedNCT00001544
• Assessment of Attentional Functioning in Children With HIV-1 InfectionCompletedNCT00001497
• Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy VolunteersCompletedNCT00001246
• Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00001206
• Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)CompletedNCT00000388Phase 4
• Cocaine Abuse and Attention Deficit Disorder - 3CompletedNCT00000268Not applicable

← Attention Deficit Disorder with Hyperactivity overview